Cargando…

A quarter of patients time their early rheumatoid arthritis onset differently than physicians

OBJECTIVE: Early rheumatoid arthritis (RA) treatment requires timely recognition. This large, multicentre study compared patient-reported vs physician-reported onset of early RA. METHODS: Patients from the Canadian Early ArThritis CoHort with early/suspected RA (persistent synovitis <1 year) comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellingwood, Leah, Kudaeva, Fatima, Schieir, Orit, Bartlett, Susan J, Bessette, Louis, Boire, Gilles, Hazlewood, Glen S, Hitchon, Carol, Keystone, Edward, Tin, Diane, Thorne, Carter, Bykerk, Vivian P, Pope, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Early Arthritis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890380/ https://www.ncbi.nlm.nih.gov/pubmed/31803498 http://dx.doi.org/10.1136/rmdopen-2019-000931

Ejemplares similares

Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort
por: Kudaeva, Fatima, et al.
Publicado: (2019)

High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years
por: Barber, Claire E. H., et al.
Publicado: (2018)

Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017‐2021: Results From the Canadian Early Arthritis Cohort
por: Ta, Viviane, et al.
Publicado: (2022)

A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort
por: Andersen, Kathleen M., et al.
Publicado: (2021)

Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort
por: Ellingwood, L., et al.
Publicado: (2019)

Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis
por: Pokharel, Gyanendra, et al.
Publicado: (2019)

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
por: Bykerk, Vivian P, et al.
Publicado: (2016)

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis
por: Hitchon, Carol A, et al.
Publicado: (2019)

Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis
por: Kuriya, B., et al.
Publicado: (2019)

Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)
por: Lee, Jason J., et al.
Publicado: (2016)

Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort
por: Guellec, Dewi, et al.
Publicado: (2015)

Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort
por: Degboé, Yannick, et al.
Publicado: (2015)

Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study
por: Akdemir, Gülşah, et al.
Publicado: (2016)

Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort
por: Guellec, Dewi, et al.
Publicado: (2016)

Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis
por: Hua, Charlotte, et al.
Publicado: (2017)

Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis
por: DAIEN, Claire Immediato, et al.
Publicado: (2017)

Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis
por: Raza, Karim, et al.
Publicado: (2016)

Diagnostic spectrum and 2-year outcome in a cohort of patients with very early arthritis
por: Norli, Ellen Sauar, et al.
Publicado: (2017)

Development of clinically apparent synovitis: a longitudinal study at the joint level during progression to inflammatory arthritis
por: ten Brinck, Robin M, et al.
Publicado: (2018)

Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study
por: ten Brinck, Robin M, et al.
Publicado: (2017)

Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives
por: Burgers, Leonie E, et al.
Publicado: (2019)

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
por: Lliso-Ribera, Gloria, et al.
Publicado: (2019)

Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales
por: Zasada, Magdalena, et al.
Publicado: (2021)

Population-based user-perceived experience of Rheumatic?: a novel digital symptom-checker in rheumatology
por: Lundberg, Karin, et al.
Publicado: (2023)

Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts
por: Sepriano, Alexandre, et al.
Publicado: (2023)

Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis
por: Triaille, Clément, et al.
Publicado: (2023)

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)
por: Barnabe, Cheryl, et al.
Publicado: (2015)

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)
por: Pope, Janet E, et al.
Publicado: (2018)

Identification of Distinct Disease Activity Trajectories in Methotrexate‐Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty‐Four Months
por: Bykerk, Vivian P., et al.
Publicado: (2021)

The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Results from the CATCH Cohort§
por: Boyd, Tristan A, et al.
Publicado: (2013)

Global Rural and Remote Patients With Rheumatoid Arthritis: A Systematic Review
por: Pianarosa, Emilie, et al.
Publicado: (2022)

Qualitative Study of Treatment Preferences for Rheumatoid Arthritis and Pharmacotherapy Acceptance: Indigenous Patient Perspectives
por: Loyola‐Sanchez, Adalberto, et al.
Publicado: (2020)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study
por: Emery, Paul, et al.
Publicado: (2019)

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)
por: Cohen, Stanley B, et al.
Publicado: (2021)

Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers
por: Carrier, Nathalie, et al.
Publicado: (2020)

Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’ are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis
por: Ghosh, Nilasha, et al.
Publicado: (2023)

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment
por: Alten, Rieke, et al.
Publicado: (2014)

Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
por: Keystone, Edward C, et al.
Publicado: (2018)

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
por: Weinblatt, Michael E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e08btig7rjmdn5l5vfiupbocar